UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

6:47 am Thursday, October 21st, 2021

(Reuters) – The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency’s website showed on Thursday.

Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Shinjini Ganguli)

6 mins ago

Brazil’s Gol says bankruptcy exit to involve $1.5 billion capital injection

17 mins ago

Bank of Israel’s statement after monetary policy meeting

20 mins ago

Bank of Israel holds rates on higher inflation, Gaza war uncertainty